TargTex is a drug development company focused on developing clinical candidates for different therapeutic indications. The company’s most advanced product is a therapy for Glioblastoma Multiforme (GBM), the most aggressive type of brain tumor with high lethality and considered an unmet medical need. This product is based on a natural product with a specific formulation that already demonstrated high efficacy in pre-clinical animal models of the disease.
- The best of 2019 in Portugal Technological from Exame Informática magazine: Honorable Mention in the category: Software
- WO/2019/054891 TRPV2 Antagonists